4//SEC Filing
Asculai Samuel 4
Accession 0001127855-13-000158
CIK 0001395400other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 2:22 PM ET
Size
4.7 KB
Accession
0001127855-13-000158
Insider Transaction Report
Form 4
Asculai Samuel
DirectorCEO10% Owner
Transactions
- Sale
Common Stock
2013-03-05−9,000,000→ 8,015,834 total(indirect: By Biostrategies Consulting Group Inc.)
Documents
Issuer
Enhance Skin Products Inc
CIK 0001395400
Entity typeother
Related Parties
1- filerCIK 0001443569
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 2:22 PM ET
- Size
- 4.7 KB